Possible factors affecting response to intravesical bacillus Calmette-Guérin (Tokyo 172 Strain) therapy for carcinoma in situ of the bladder: A multivariate analysis

1998 ◽  
Vol 30 (6) ◽  
pp. 713-722 ◽  
Author(s):  
M. Takashi ◽  
S. Katsuno ◽  
H. Yuba ◽  
S. Ohshima ◽  
K. Wakai ◽  
...  
Keyword(s):  
Multivariate Analysis ◽  
Carcinoma In Situ ◽  
Bacillus Calmette Guerin ◽  
Factors Affecting

Factors Affecting Valrubicin Response in Patients with Bacillus Calmette-Guérin–Refractory Bladder Carcinoma in Situ

2011 ◽  
Vol 123 (3) ◽  
pp. 28-34 ◽  
Author(s):  
Gary D. Steinberg ◽  
Norm D. Smith ◽  
Kevin Ryder ◽  
Nicole M. Strangman ◽  
Simon J. Slater
Keyword(s):  
Bladder Carcinoma ◽  
Carcinoma In Situ ◽  
Bacillus Calmette Guerin ◽  
Factors Affecting

Factors Affecting Response to Bacillus Calmette-Guérin Plus Interferon for Urothelial Carcinoma in Situ

2011 ◽  
Vol 186 (3) ◽  
pp. 817-823 ◽  
Author(s):  
Henry M. Rosevear ◽  
Andrew J. Lightfoot ◽  
Kevin K. Birusingh ◽  
José L. Maymí ◽  
Kenneth G. Nepple ◽  
...  
Keyword(s):  
Urothelial Carcinoma ◽  
Carcinoma In Situ ◽  
Bacillus Calmette Guerin ◽  
Factors Affecting

Clinical outcome of bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract

2002 ◽  
Vol 9 (12) ◽  
pp. 677-680 ◽  
Author(s):  
HIDEAKI MIYAKE ◽  
HIROSHI ETO ◽  
SHOJI HARA ◽  
HIROSHI OKADA ◽  
SADAO KAMIDONO ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Clinical Outcome ◽  
Carcinoma In Situ ◽  
Upper Urinary Tract ◽  
Bacillus Calmette Guerin

Ductal carcinoma in situ: Factors affecting recurrence

1998 ◽  
Vol 34 ◽  
pp. S8
Author(s):  
L.Y. Hiew ◽  
S. Stallard ◽  
A.D. Purushotham ◽  
H. Mehana ◽  
C. Cordiner ◽  
...  
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Factors Affecting

scholarly journals MP50-05 IMPACT OF BACILLUS CALMETTE-GUéRIN THERAPY OF UPPER URINARY TRACT CARCINOMA IN SITU: COMPARISON OF ONCOLOGICAL OUTCOMES WITH RADICAL NEPHROURETERECTOMY

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Hirotaka Horiguchi* ◽  
Shingo Hatakeyama ◽  
Hayato Yamamoto ◽  
Atsushi Imai ◽  
Takahiro Yoneyama ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Carcinoma In Situ ◽  
Upper Urinary Tract ◽  
Bacillus Calmette Guerin ◽  
Radical Nephroureterectomy ◽  
Oncological Outcomes ◽  
Upper Urinary Tract Carcinoma

Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: Defining the risk of initial bladder preservation

Urology ◽  
2006 ◽  
Vol 67 (4) ◽  
pp. 737-741 ◽  
Author(s):  
Alan M. Nieder ◽  
Michael A. Simon ◽  
Sandy S. Kim ◽  
Murugesan Manoharan ◽  
Mark S. Soloway
Keyword(s):  
High Risk ◽  
Radical Cystectomy ◽  
Carcinoma In Situ ◽  
Bacillus Calmette Guerin ◽  
Bladder Preservation

Possibile ruolo della citofluorometria (CFM) nel monitoraggio della risposta alla terapia endocavitaria con BCG nel carcinoma in situ della vescica: Monitoring the response to intravesical BCG in the treatment of cis: A possible role of flow cytometry

1995 ◽  
Vol 62 (2) ◽  
pp. 245-247
Author(s):  
M. De Siati ◽  
D. Grassi ◽  
N. Franzolin ◽  
L.S. Azzolina
Keyword(s):  
Flow Cytometry ◽  
Carcinoma In Situ ◽  
Recurrent Disease ◽  
Intravesical Therapy ◽  
Urinary Cytology ◽  
Bacillus Calmette Guerin ◽  
Intravesical Bcg

We report our experience on the treatment of carcinoma in situ (CIS) using intravesical therapy with the Bacillus Calmette-Guerin (BCG). From November 1992 to September 1994, 18 patients received treatment: 6 had associated CIS and 12 secondary CIS. Ploidy of each tumour was determined by flow cytometry. Aneuploidy was found in 12 cases, diploidy in 6 cases. After treatment, a standard bladder mapping was performed: 14 patients showed no evidence of cystoscopic and histological disease and if previously aneuploid, became diploid. 4 patients has recurrent disease after therapy; they were all aneuploid before treatment. One of these showed a persistent aneuploidy, although both voided urinary cytology and histological samples were negative. Six months later, a recurrent CIS was seen at the time of cystoscopy. These results enhance the interest in flow cytometry as a possible predictor of response to BCG in the treatment of CIS.

Urothelial Carcinoma In Situ and Treatment of Bacillus Calmette-Guérin Failures

2019 ◽  
pp. 337-349
Author(s):  
David D’Andrea ◽  
Fred Witjes ◽  
Francesco Soria ◽  
Shahrokh F. Shariat
Keyword(s):  
Urothelial Carcinoma ◽  
Carcinoma In Situ ◽  
Bacillus Calmette Guerin

The Use of Bacillus Calmette-Guerin in the Therapy of Bladder Carcinoma in Situ

1985 ◽  
Vol 134 (1) ◽  
pp. 36-39 ◽  
Author(s):  
Stanley A. Brosman
Keyword(s):  
Bladder Carcinoma ◽  
Carcinoma In Situ ◽  
Bacillus Calmette Guerin
Sign in / Sign up

Export Citation Format

Share Document